Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
|Articles|July 17, 2023
News Roundup: July 10 to July 16
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
AI Streamlines Pharmacy Workflow
Artificial intelligence can be a key tool for streamlining pharmacy workflows.
NJ Governor Phil Murphy Signs PBM, Drug Price Legislation
Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.
Many Patients With COPD Have Poor Adherence to Long-Acting Inhalers
Researchers encourage physicians to personalize care plans to ensure that more patients adhere to their inhalers.
Study Explores Link Between Chronic Viral Infections and Long COVID
Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.
Can Post-Exposure Doxycycline Prevent Sexually Transmitted Infections?
A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.
Advertisement
Related to this article
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Erin Albert of Mark Cuban Cost Plus Drugs explains how the Team Cuban Card offers transparent pricing and fair pay for independent pharmacies.
An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Advertisement
Advertisement
Trending on Drug Topics
1
CVS Plans to Split Off Its Retail Pharmacies, Keeping Specialty Operations
2
Team Cuban Card Includes Transparent Pricing for Cash Patients
3
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
4
The Future of HIV PrEP and One Step to Take Tomorrow
5